Tumor chemosensitivity and chemoresistance assays

Cancer

Volumn 77, Issue 6, 1996, Pages 1020-1025

  Brown, Elizabeth ^a   Markman, Maurie ^b  

^a AETNA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cancer chemotherapy; chemoresistance assays; chemosensitivity assays; clonogenic assays

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOSENSITIVITY; DIAGNOSTIC PROCEDURE; DRUG SAFETY; DRUG TOXICITY; HUMAN; NOTE; PRIORITY JOURNAL; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; SALVAGE THERAPY;

EID: 0029990074     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960315)77:6<1020::AID-CNCR3>3.0.CO;2-L     Document Type: Note

References (12)

1. Freuhauf JP, Bosanquet AG. In vitro determination of drug response: A discussion of clinical applications. PPO Updates 1993;12:1-16.
2. Hamburger A, Salmon S. Primary bioassay of human tumor stem cells. Science 1977;197:461-5.
3. Salmon SE, Hamburger AW, Soehnlen B, Durie BGM, Alberts DS, Moon TE. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med 1978;298:1321-7.
4. Sondak VK, Bertelsen CA, Tanigawa N, Hildebrand-Zanki SU, Morton DL, Korn EL, et al. Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay. Cancer Res 1984;44:1725-8.
5. Von Hoff DD. Send this patient's tumor for culture and sensitivity. N Engl J Med 1983;308:154-5.
6. Kern DH, Brogemuller CR, Kennedy MC, Hildebrand-Zanki SU, Tanigawa N, Sondak VK. Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors. Cancer Res 1985;45:5436-41.
7. Kern DH, Weisenthal LM. Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures. J Natl Cancer Inst 1990; 82:582-8.
8. Von Hoff DD. He's not going to talk about in vitro predictive assays again, is he? J Natl Cancer Inst 1990;82:96-101.
9. Federico M, Alberts DS, Garcia DJ, Emerson J, Fanta P, Liu R. et al. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: Comparison of in vitro response and clinical outcome. Gynecol Oncol 1994;55: S156-63.
10. Von Hoff DD, Sandbach JF, Clark GM, Turner JN, Forseth BF, Piccart MJ, et al. Selection of cancer chemotherapy for a patient by an in vitro assay vs. a clinician. J Natl Cancer Inst 1990;82:110-6.
11. Gazdar AF, Steinberg SM, Russell EK, Linnoila RI, Oie HK, Gohsh BC, et al. Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival in extensive stage small cell lung cancer: A prospective clinical trial. J Natl Cancer Inst 1990;82:117-24.
12. Maenpaa JU, Heinonen E, Hinkka SM, Karnani P, Klemi PJ, Korpijaakko TA, et al. The subrenal capsule assay in selecting chemotherapy for ovarian cancer: A prospective randomized trial. Gynecol Oncol 1995;57:294-8.